Research on SGLT2 inhibitors in #gout is needed. They have been shown to reduce uric acid & gout flares, and may be uricosuric or be antiinflammatory. Also decreased incident gout (by half) among at-risk patients with type 2 diabetes (HR 0.54) https://t.co/ZEmhwqyDOv https://t.co/58YKD6pFyt
Links:
The clinical benefits of sodium–glucose cotransporter type 2 inhibitors in peop…
https://buff.ly/3xaXlgj
Mar-25-2024


